Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation method of viscoelastic agent with cohesiveness and dispersivity

A dispersive and cohesive technology, used in medical science, surgery, etc., can solve the problems of inability to meet filling and support functions, low molecular weight, and low elasticity.

Inactive Publication Date: 2016-08-31
SHANGHAI QISHENG BIOLOGICAL PREPARATION CO LTD
View PDF8 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the single use of dispersible viscoelastic agents also has major problems, mainly because the products have low molecular weight and low elasticity but cannot meet the preoperative filling and supporting functions. After that, it cannot be completely sucked out from the eye, resulting in complications such as increased intraocular pressure caused by residue in the eye
[0004] It can be seen that a single dispersive or cohesive viscoelastic agent cannot achieve a very ideal use effect, so it is necessary to develop an ophthalmic viscoelastic agent with both dispersible and cohesive properties, and combine the respective advantages of the two to achieve It not only has good filling and supporting functions, but also has good intraocular clearance properties
There is no such product on the market so far

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of viscoelastic agent with cohesiveness and dispersivity
  • Preparation method of viscoelastic agent with cohesiveness and dispersivity
  • Preparation method of viscoelastic agent with cohesiveness and dispersivity

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0020] Weigh 1g of sodium hyaluronate dry powder, 1g of chitosan dry powder and dissolve in 50mL of phosphate buffer solution to prepare a mixed gel solution with a sodium hyaluronate solution concentration of 2% and a chitosan solution concentration of 2%. Let it stand until it dissolves evenly, and then sterilize under high temperature and high pressure at 121°C for 15 minutes.

Embodiment 2

[0022] Weigh 1 g of sodium hyaluronate dry powder, and dissolve 0.75 g of chitosan dry powder in 50 mL of phosphate buffer solution to prepare a mixed gel solution in which the concentration of sodium hyaluronate solution is 2%, and the concentration of chitosan solution is 1.5%. Let it stand at low temperature until it dissolves evenly, and then sterilize under high temperature and high pressure at 121°C for 15 minutes.

Embodiment 3

[0024] Weigh 1 g of sodium hyaluronate dry powder, and dissolve 0.5 g of chitosan dry powder in 50 mL of phosphate buffer solution to prepare a mixed gel solution in which the concentration of sodium hyaluronate solution is 2%, and the concentration of chitosan solution is 1%. Let it stand at low temperature until it dissolves evenly, and then sterilize under high temperature and high pressure at 121°C for 15 minutes.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
molecular weightaaaaaaaaaa
Login to View More

Abstract

Single cohesiveness or dispersivity cannot simultaneously satisfy different needs in the whole cataract surgery. Chitosan and sodium hyaluronate respectively belong to natural polycation and polyanion polysaccharides. Through charge interaction between chitosan and sodium hyaluronate, a polyelectrolyte complex is formed and the polyelectrolyte complex is processed to form the viscoelastic agent with cohesiveness and dispersivity. Medical chitosan gel has thermolability and after moist heat sterilization, the molecular weight of the chitosan gel is reduced and dispersivity is improved so that the chitosan gel can prevent corneal tissue mechanical damage. After positive and negative charge interaction, ionic crosslinked compound gel still has good cohesiveness, still has typical non-Newton rheological behavior and can be removed easily and reduce residual in eyes. Cohesiveness and dispersivity guarantees that a single product can satisfy demands in different stages in the whole cataract surgery and has a wide clinical application prospect.

Description

technical field [0001] The invention relates to the technical field of medical biomaterials, in particular to a method for preparing a viscoelastic agent with both cohesive and dispersible properties. Combined to form a viscoelastic agent with both cohesive and diffusive properties, it provides an ideal biomedical material for the whole process of cataract surgery. Background technique [0002] Cataract has been a common ophthalmic disease for a long time, and cataract is the leading cause of blindness in both developed and developing countries. With the aging society in various countries, the incidence of cataract and ophthalmic diseases is also increasing. Medical surgery is the most effective means to restore the eyesight of cataract patients. In recent years, with the development and maturity of microsurgical technology, ultrasound Emulsification cataract surgery has become the mainstream of cataract and ophthalmic surgery at home and abroad because of its small surgica...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61L31/04A61L31/14
CPCA61L31/042A61L31/14C08L5/08
Inventor 魏长征宋瑞瑞蒋丽霞
Owner SHANGHAI QISHENG BIOLOGICAL PREPARATION CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products